Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Synlait Milk Ltd. ( (AU:SM1) ) is now available.
Synlait Milk Limited announced that the Overseas Investment Office has approved the sale of its North Island assets to Abbott, a global healthcare leader. The assets include the Pōkeno manufacturing facility and Auckland sites, with the transaction valued at US$178 million and expected to complete by April 2026, pending customary consents and shareholder approval.
The most recent analyst rating on (AU:SM1) stock is a Hold with a A$0.72 price target. To see the full list of analyst forecasts on Synlait Milk Ltd. stock, see the AU:SM1 Stock Forecast page.
More about Synlait Milk Ltd.
Synlait Milk Limited is a company operating in the dairy industry, primarily focused on manufacturing and supplying dairy products. The company has a significant presence in New Zealand, with its operations including manufacturing facilities and distribution sites.
Average Trading Volume: 43,570
Technical Sentiment Signal: Hold
Current Market Cap: A$394.6M
For detailed information about SM1 stock, go to TipRanks’ Stock Analysis page.